CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-28 | Fenimore Christopher R. SVP Finance & CFO | Sale | −766 | $1,205.44 | $923K | 200 |
| 2024-08-28 | Fenimore Christopher R. SVP Finance & CFO | Sale | −200 | $1,206.30 | $241K | 0 |
| 2024-08-28 | Fenimore Christopher R. SVP Finance & CFO | Sale | −2,237 | $1,204.71 | $2.7M | 1,378 |
| 2024-08-28 | Fenimore Christopher R. SVP Finance & CFO | Sale | −928 | $1,205.49 | $1.1M | 450 |
| 2024-08-28 | Fenimore Christopher R. SVP Finance & CFO | Sale | −450 | $1,206.15 | $543K | 0 |
| 2024-08-28 | Fenimore Christopher R. SVP Finance & CFO | Sale | −236 | $1,205.67 | $285K | 225 |
| 2024-08-28 | Fenimore Christopher R. SVP Finance & CFO | Sale | −200 | $1,206.70 | $241K | 25 |
| 2024-08-28 | Fenimore Christopher R. SVP Finance & CFO | Sale | −235 | $1,205.67 | $283K | 225 |
| 2024-08-28 | Fenimore Christopher R. SVP Finance & CFO | Sale | −200 | $1,206.67 | $241K | 25 |
| 2024-08-15 | Bassler Bonnie L Director | Option exercise 10b5-1 | +756 | $371.40 | $281K | 2,138 |
| 2024-08-15 | Bassler Bonnie L Director | Sale 10b5-1 | −756 | $1,170.00 | $885K | 1,382 |
| 2024-08-15 | Bassler Bonnie L Director | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −756 | 1,516 | ||
| 2024-08-15 | POON CHRISTINE A Director | Option exercise | +10,838 | $413.33 | $4.5M | 13,010 |
| 2024-08-15 | POON CHRISTINE A Director | Sale | −1,012 | $1,155.72 | $1.2M | 11,998 |
| 2024-08-15 | POON CHRISTINE A Director | Sale | −2,368 | $1,156.30 | $2.7M | 9,630 |
| 2024-08-15 | POON CHRISTINE A Director | Sale | −1,560 | $1,157.33 | $1.8M | 8,070 |
| 2024-08-15 | POON CHRISTINE A Director | Sale | −212 | $1,158.02 | $246K | 7,858 |
| 2024-08-15 | POON CHRISTINE A Director | Sale | −5,352 | $1,159.56 | $6.2M | 2,506 |
| 2024-08-15 | POON CHRISTINE A Director | Sale | −234 | $1,160.45 | $272K | 2,272 |
| 2024-08-15 | POON CHRISTINE A Director | Sale | −100 | $1,161.32 | $116K | 2,172 |
Page 19 of 49 · 971 trades